BlueSphere Bio, the first company to spin out of UPMC Enterprises’ Translational Sciences focus area, has named industry veteran David Apelian, MD, PhD, MBA, as the company’s CEO.
CEO named for first UPMC Enterprises’ Translational Sciences spin-out
August 25, 2019